Friday, May 1, 2026

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1 Data

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

South Korea and U.S. Reaffirm Commitment to Strong Defense Ties Amid Rising Regional Threats

South Korea's Defense Minister Kim Sun Ho and U.S. Secretary of Defense Pete Hegseth reaffirmed their alliance.

Tag: population trends

Knee Osteoarthritis on the Rise in South Korea’s Super-Aged Society

South Korea has entered a 'super-aged society' with over 20% of the population aged 65+, highlighting the need for elder care.

Top News

- Our Sponsors Ad -

Follow us